Wanhe Luo

631 total citations
32 papers, 443 citations indexed

About

Wanhe Luo is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Wanhe Luo has authored 32 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 10 papers in Molecular Biology and 6 papers in Biomaterials. Recurrent topics in Wanhe Luo's work include Advanced Drug Delivery Systems (10 papers), Advancements in Transdermal Drug Delivery (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Wanhe Luo is often cited by papers focused on Advanced Drug Delivery Systems (10 papers), Advancements in Transdermal Drug Delivery (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Wanhe Luo collaborates with scholars based in China, Egypt and Pakistan. Wanhe Luo's co-authors include Samah Attia Algharib, Yuanhu Pan, Ali Dawood, Shuyu Xie, Yulian Wang, Aoxue Zhang, Yuanyuan Yan, Qin Wu, Junpeng Hu and Meifang Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Langmuir and Carbohydrate Polymers.

In The Last Decade

Wanhe Luo

30 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanhe Luo China 10 110 107 106 91 67 32 443
Samah Attia Algharib Egypt 15 163 1.5× 151 1.4× 142 1.3× 130 1.4× 105 1.6× 39 757
Hongyun Lu China 7 153 1.4× 82 0.8× 46 0.4× 68 0.7× 104 1.6× 11 484
Bushra Jamil Pakistan 12 105 1.0× 142 1.3× 70 0.7× 124 1.4× 69 1.0× 21 493
Mojtaba Nabili Iran 17 92 0.8× 134 1.3× 104 1.0× 25 0.3× 133 2.0× 52 817
Wasana Chaisri Thailand 11 54 0.5× 96 0.9× 78 0.7× 53 0.6× 46 0.7× 35 354
Durairajan Rubini India 13 198 1.8× 190 1.8× 32 0.3× 69 0.8× 64 1.0× 20 529
Madhuri Singh India 10 229 2.1× 144 1.3× 61 0.6× 78 0.9× 63 0.9× 20 785
Harmanmeet Kaur India 13 89 0.8× 150 1.4× 226 2.1× 130 1.4× 94 1.4× 30 621
Sara Primavilla Italy 14 69 0.6× 137 1.3× 27 0.3× 65 0.7× 35 0.5× 37 407
Yasunori Maeda United Kingdom 10 141 1.3× 68 0.6× 30 0.3× 95 1.0× 102 1.5× 21 495

Countries citing papers authored by Wanhe Luo

Since Specialization
Citations

This map shows the geographic impact of Wanhe Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanhe Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanhe Luo more than expected).

Fields of papers citing papers by Wanhe Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanhe Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanhe Luo. The network helps show where Wanhe Luo may publish in the future.

Co-authorship network of co-authors of Wanhe Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Wanhe Luo. A scholar is included among the top collaborators of Wanhe Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanhe Luo. Wanhe Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Wanhe, Jinhuan Wang, Yongtao Jiang, et al.. (2025). Multifunctional nanogel dressings with dual acid and H2O2 responsive release for synergetic therapy of diabetic bacterial wounds. Materials Today Bio. 33. 102094–102094. 1 indexed citations
2.
Luo, Wanhe, Mengdi Zhang, Yongtao Jiang, et al.. (2025). Manipulated Slow Release of Florfenicol Hydrogels for Effective Treatment of Anti-Intestinal Bacterial Infections. International Journal of Nanomedicine. Volume 20. 541–555. 2 indexed citations
3.
Wang, Jinhuan, Yongtao Jiang, Ning Du, et al.. (2025). Enhanced Antibacterial Effect of pH/Gelatinase-Responsive Florfenicol Nanogels Against Staphylococcus aureus. International Journal of Nanomedicine. Volume 20. 5193–5208. 1 indexed citations
4.
Zhang, Mengdi, Jindong Gao, Muhammad Fakhar‐e‐Alam Kulyar, et al.. (2024). Antioxidant and renal protective effects of Nano-selenium on adenine-induced acute renal failure in canines. Ecotoxicology and Environmental Safety. 287. 117274–117274.
5.
Luo, Wanhe, Jinhuan Wang, Mengdi Zhang, et al.. (2024). Florfenicol core–shell composite nanogels as oral administration for efficient treatment of bacterial enteritis. International Journal of Pharmaceutics. 662. 124499–124499. 1 indexed citations
7.
Algharib, Samah Attia, et al.. (2024). Basic concepts, recent advances, and future perspectives in the diagnosis of bovine mastitis. Journal of Veterinary Science. 25(1). e18–e18. 6 indexed citations
8.
Dawood, Ali, Mohamed Nayel, Akram Salama, et al.. (2023). Brucellae as resilient intracellular pathogens: epidemiology, host–pathogen interaction, recent genomics and proteomics approaches, and future perspectives. Frontiers in Veterinary Science. 10. 1255239–1255239. 16 indexed citations
9.
Luo, Wanhe, et al.. (2023). On-demand release of enrofloxacin-loaded chitosan oligosaccharide-oxidized hyaluronic acid composite nanogels for infected wound healing. International Journal of Biological Macromolecules. 253(Pt 6). 127248–127248. 14 indexed citations
11.
Luo, Wanhe, et al.. (2023). Down-regulation of β-lactam antibiotics resistance and biofilm formation by Staphylococcus epidermidis is associated with isookanin. Frontiers in Cellular and Infection Microbiology. 13. 1139796–1139796. 6 indexed citations
12.
Luo, Wanhe, Kuiyu Meng, Jinhuan Wang, et al.. (2023). Guar gum modified tilmicosin-loaded sodium alginate/gelatin composite nanogels for effective therapy of porcine proliferative enteritis caused by Lawsonia intracellularis. International Journal of Biological Macromolecules. 242(Pt 3). 125084–125084. 5 indexed citations
13.
Algharib, Samah Attia, et al.. (2022). Antibacterial activity of florfenicol composite nanogels against Staphylococcus aureus small colony variants. Journal of Veterinary Science. 23(5). e78–e78. 4 indexed citations
15.
16.
17.
Liu, Yana, Qin Wu, Samah Attia Algharib, et al.. (2021). Structure, preparation, modification, and bioactivities of β-glucan and mannan from yeast cell wall: A review. International Journal of Biological Macromolecules. 173. 445–456. 143 indexed citations
18.
Luo, Wanhe, Hua Qin, Dongmei Chen, et al.. (2020). The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model. Microbial Pathogenesis. 147. 104389–104389. 16 indexed citations
19.
Liu, Yuda, Dongmei Chen, Aoxue Zhang, et al.. (2020). Composite inclusion complexes containing hyaluronic acid/chitosan nanosystems for dual responsive enrofloxacin release. Carbohydrate Polymers. 252. 117162–117162. 47 indexed citations
20.
Tao, Yanfei, Fei Yang, Kuiyu Meng, et al.. (2019). Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig. Drug Delivery. 26(1). 273–280. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026